OXFORD GENETICS
Oxford Genetics is a UK-based biotechnology company specializing in the production of versatile cloning plasmids for research in academic and biotechnology institutions. They also provide custom cloning and DNA synthesis. All of their products are free of intellectual property restrictions.
OXFORD GENETICS
Industry:
Biotechnology Genetics
Founded:
2011-04-28
Address:
Upper Heyford, Somerset, United Kingdom
Country:
United Kingdom
Website Url:
http://www.oxgene.com
Total Employee:
51+
Status:
Active
Contact:
+44 18 6923 8004
Email Addresses:
[email protected]
Total Funding:
16.76 M GBP
Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS Cloudflare JS Microsoft Microsoft Azure Shutterstock Symantec Secure Site KnowBe4
Current Employees Featured
Founder
Investors List
Mercia Asset Management PLC
Mercia Asset Management PLC investment in Venture Round - Oxford Genetics
Mercia Asset Management PLC
Mercia Asset Management PLC investment in Venture Round - Oxford Genetics
Invesco Perpetual
Invesco Perpetual investment in Venture Round - Oxford Genetics
Mercia Asset Management PLC
Mercia Asset Management PLC investment in Venture Round - Oxford Genetics
Mercia Asset Management PLC
Mercia Asset Management PLC investment in Grant - Oxford Genetics
Innovate UK
Innovate UK investment in Grant - Oxford Genetics
Mercia Fund Managers
Mercia Fund Managers investment in Venture Round - Oxford Genetics
Mercia Fund Managers
Mercia Fund Managers investment in Seed Round - Oxford Genetics
Newest Events participated
Participated in Cell & Gene Therapy Bioprocessing & Commercialization 2017
on 2017-09-25 as exhibitor
Participated in Viral Safety 2017
on 2017-04-25 as sponsor
Participated in BioProcess International European Summit 2017
on 2017-04-25 as sponsor
Participated in Cell Line Development & Engineering 2017
on 2017-04-24 as sponsor
Official Site Inspections
http://www.oxgene.com
- Host name: acd89244c803f7181.awsglobalaccelerator.com
- IP address: 75.2.60.5
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "Oxford Genetics"
OXGENE | Lab Manager
Organization profile for OXGENE on Lab Manager. OXGENE OXGENE, a WuXi Advanced Therapies company, accelerates the delivery of gene therapy and biologics with its scalable …See details»
WuXi AppTec Completes Acquisition of OXGENE to Further …
Mar 1, 2021 PHILADELPHIA and OXFORD, March 2, 2021 - WuXi AppTec, a leading global provider of R&D- and manufacturing-enabling services in the pharmaceutical, biotechnology …See details»
OXGENE - LinkedIn
OXGENE, a WuXi Advanced Therapies (WuXi ATU) company, based in Oxford, UK, provides cell and gene therapy pioneers around the world with the technologies, automation platforms and service ...See details»
Oxford Genetics - Crunchbase Company Profile
OXGENE has developed TESSA technology to simplify the manufacturing of adeno-associated viral vectors, enhancing scalability and reducing costs. …See details»
Contact OXGENE - Advanced Therapies
Organization. Message (Required) Let’s stay in touch. Please add me to your mailing list. Phone. This field is for validation purposes and should be left unchanged. ... OXGENE is located in …See details»
OXGENE - Products, Competitors, Financials, Employees, …
About OXGENE. OXGENE's technology platforms and solutions accelerate the discovery, development, and manufacture of cell and gene therapies. The firm provides high-titer viral …See details»
OXGENE Company Profile - Office Locations, Competitors, …
OXGENE has 5 employees across 2 locations and £1.01 m in annual revenue in FY 2018. See insights on OXGENE including office locations, competitors, revenue, financials, executives, …See details»
WuXi absorbs Oxgene to up cell and gene services
Mar 4, 2021 Oxgene, which will retain its name, is a contract research and development organization based in Oxford, UK, that provides cell and gene therapy discovery and biomanufacturing platforms. The company offers …See details»
OXGENE (Oxford Genetics) - VentureRadar
May 1, 2020 OXGENE find solutions to seemingly impossible problems. We develop new technologies in mammalian cell engineering along the whole spectrum from discovery science …See details»
WuXi AppTec Completes Acquisition of OXGENE to Further …
Mar 2, 2021 OXGENE will become a fully-owned subsidiary of WuXi Advanced Therapies (WuXi ATU), WuXi AppTec's cell and gene therapy Contract Testing, Development and …See details»
OXGENE Profile | The Scientist
May 10, 2021 Content provided by OXGENE. Agilent BioTek Cytation C10 Confocal Imaging Reader. From confocal, widefield, and live cell imaging to multimode reading, the Agilent …See details»
WuXi AppTec Completes Acquisition of OXGENE to Further
Mar 2, 2021 OXGENE will become a fully-owned subsidiary of WuXi Advanced Therapies (WuXi ATU), WuXi AppTec's cell and gene therapy Contract Testing, Development and …See details»
Oxgene Company Profile Funding & Investors | YourStory
OXGENE, a WuXi Advanced Therapies (WuXi ATU) company, based in Oxford, UK, provides cell and gene therapy pioneers around the world with the technologies, automation platforms and …See details»
Oxford Genetics Company Information - Funding, Investors, and …
Key Insights: Oxford Genetics funding round, March 28, 2019: $8m Oxford Genetics seed round: $227.29k Oxford Genetics Venture round, July 2015: $698.74k Oxford Genetics Grant …See details»
OXGENE Company Profile: Funding, Investors & Partnerships
OXGENEâ„¢, a leader in synthetic biology, is a specialised contract research organisation offering services to support the discovery, development and production of biologics, gene and cell …See details»
Advanced Therapies Discovery Services from OXGENE
OXGENE’s SnapFastâ„¢ plasmids are versatile and efficient. These modular plasmids are designed to work like ‘molecular building blocks’, using a catalogue of well characterized DNA …See details»
OXGENE Eyes Further Growth in Cell and Gene Therapy Services …
Mar 3, 2021 OXGENE—founded in 2011 as Oxford Genetics Ltd. and re-branded in 2019—will continue operations under its own name as a wholly-owned subsidiary of WuXi AppTec’s cell …See details»
Viralgen Joins Orphan Therapeutics Accelerator Clinical …
11 hours ago Viralgen, founded in 2017 as a subsidiary of AskBio Inc. within the Bayer AG group, is a contract development and manufacturing organization specializing in the large …See details»
WuXi AppTec Completes Acquisition of OXGENE to Further …
Mar 3, 2021 PHILADELPHIA and OXFORD, March 2, 2021 - WuXi AppTec, a leading global provider of R&D- and manufacturing-enabling services in the pharmaceutical, biotechnology …See details»
WuXi AppTec Completes Acquisition of OXGENE to Further
PHILADELPHIA and OXFORD, March 2, 2021 /PRNewswire/ --WuXi AppTec, a leading global provider of R&D- and manufacturing-enabling services in the pharmaceutical, biotechnology …See details»